With over 7,000 medicines and vaccines in development globally for a wide range of diseases, an exciting new wave of medical innovation will play a key role in addressing the challenges faced by patients and by the NHS.

Some of the most impactful new therapies in development are include combination therapies for cancer; disease-modifying therapies for Alzheimer’s; antibacterial monoclonal antibodies to target antimicrobial resistance; gene therapies against haemophilia; cell therapies against diabetes; and CAR-T therapies targeting blood cancers.